ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

NCI, NHGRI Fund Two More Components of TCGA Project.

October 27, 2006

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

FDA Approves Medication For Smoking Cessation

May 26, 2006

NCI Advisory Group, Other Cancer Meetings

August 19, 1983